The DYNAMIC Trial: Is it the Right Option for You?
Unlock efficiency and cost-effectiveness in cancer drug development with TD2’s innovative DYNAMIC Trial Design, aligning with the FDA’s call for adaptive approaches to trial structures. By incorporating exploratory cohorts earlier in the development process, the DYNAMIC Trial streamlines Phase II design, achieving in one multiple-arm trial what traditional models accomplish in several independent studies. Benefit from significant cost savings, accelerated patient enrollment, reduced trial duration, and strategic clarity based on real results obtained from multiple Phase I cohorts. While challenges exist, if you have multiple hypotheses, seek to validate anecdotal evidence, or lack a clear direction post-Phase I, the DYNAMIC Trial Design offers a compelling solution for optimum results.
